Daily Stock Analysis, ANIP, ANI Pharmaceuticals Inc, priceseries

ANI Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
48.69
Close
48.90
High
48.95
Low
48.00
Previous Close
48.50
Daily Price Gain
0.40
YTD High
65.81
YTD High Date
Feb 16, 2017
YTD Low
43.71
YTD Low Date
Mar 21, 2017
YTD Price Change
-12.37
YTD Gain
-20.19%
52 Week High
70.92
52 Week High Date
Aug 15, 2016
52 Week Low
30.60
52 Week Low Date
Mar 29, 2016
52 Week Price Change
16.50
52 Week Gain
50.93%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 9. 2015
59.28
Mar 3. 2015
65.50
15 Trading Days
10.49%
Link
LONG
Jul 10. 2015
62.22
Jul 24. 2015
68.27
10 Trading Days
9.72%
Link
LONG
Feb 19. 2016
30.44
Mar 10. 2016
33.67
14 Trading Days
10.60%
Link
LONG
Mar 31. 2016
33.66
Apr 29. 2016
45.39
21 Trading Days
34.84%
Link
LONG
May 24. 2016
50.09
Jun 9. 2016
54.16
11 Trading Days
8.12%
Link
LONG
Jul 18. 2016
56.01
Aug 19. 2016
68.19
24 Trading Days
21.75%
Link
Company Information
Stock Symbol
ANIP
Exchange
NasdaqGM
Company URL
http://www.anipharmaceuticals.com
Company Phone
2186343500
CEO
Arthur S. Przybyl
Headquarters
Minnesota
Business Address
210 MAIN STREET WEST, BAUDETTE, MN 56623
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001023024
About

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States.

Description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. The company focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It offers Esterified Estrogen with Methyltestosterone for use in treating vasomotor symptoms of menopause; Etodolac used to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Flecainide for treating arrhythmia; Fluvoxamine for use in treating obsessive-compulsive disorders and social anxiety disorders; Hydrocortisone Enema and Cortenema used to treat ulcerative colitis; and Methazolamide for treating ocular conditions. The company also provides Metoclopramide and Reglan for treating gastroesophageal reflux; Nimodipine that reduces the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone oral solution, which relieves pain; Propafenone used to treat arrhythmia; Lithobid for treating the manic episodes of bipolar disorder; and Vancocin and Vancocin for use in treating C. difficile-associated diarrhea, as well as enterocolitis caused by staphylococcus aureus. In addition, it provides contract manufacturing services for other pharmaceutical companies. The company markets and sells its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.